Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:RHHBY
- CUSIP: N/A
- Web: www.roche.com
- 50 Day Moving Avg: $32.96
- 200 Day Moving Avg: $30.58
- 52 Week Range: $25.25 - $36.82
Sales & Book Value:
- Trailing P/E Ratio: 24.43
- Foreward P/E Ratio: 16.86
- P/E Growth: 0.00
- Annual Revenue: $52.98 billion
- Price / Sales: N/A
- Book Value: $3.53 per share
- Price / Book: 9.69
- Average Volume: 1.03 million shs.
Frequently Asked Questions for Roche Holding (NASDAQ:RHHBY)
What is Roche Holding's stock symbol?
Roche Holding trades on the NASDAQ under the ticker symbol "RHHBY."
Where is Roche Holding's stock going? Where will Roche Holding's stock price be in 2017?
7 brokers have issued 12 month price objectives for Roche Holding's shares. Their predictions range from $33.37 to $33.37. On average, they expect Roche Holding's share price to reach $33.37 in the next year. View Analyst Ratings for Roche Holding.
Who are some of Roche Holding's key competitors?
Some companies that are related to Roche Holding include Johnson & Johnson (JNJ), Novartis AG (NVS), Pfizer (PFE), Merck & Co. (MRK), UnitedHealth Group (UNH), Sanofi SA (SNY), Medtronic plc. (MDT), Bayer AG (BAYRY), Amgen (AMGN), AbbVie (ABBV), GlaxoSmithKline plc (GSK), Novo Nordisk A/S (NVO), Celgene (CELG), Bristol-Myers Squibb Co (BMY), AstraZeneca plc (AZN), Gilead Sciences (GILD), Eli Lilly and Co (LLY) and Abbott Laboratories (ABT).
Who owns Roche Holding stock?
Roche Holding's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (0.00%), Parametric Portfolio Associates LLC (0.00%), Schafer Cullen Capital Management Inc. (0.00%), Bristol John W & Co. Inc. NY (0.00%), Riverbridge Partners LLC (0.00%) and Moody Lynn & Lieberson LLC (0.00%). View Institutional Ownership Trends for Roche Holding.
Who sold Roche Holding stock? Who is selling Roche Holding stock?
Roche Holding's stock was sold by a variety of institutional investors in the last quarter, including Bristol John W & Co. Inc. NY, Commerce Bank, Scout Investments Inc., Blair William & Co. IL, Cape Cod Five Cents Savings Bank, Tower Bridge Advisors, Wendell David Associates Inc. and Thomas White International Ltd.. View Insider Buying and Selling for Roche Holding.
Who bought Roche Holding stock? Who is buying Roche Holding stock?
Roche Holding's stock was acquired by a variety of institutional investors in the last quarter, including Parametric Portfolio Associates LLC, Moody Lynn & Lieberson LLC, Schafer Cullen Capital Management Inc., Fisher Asset Management LLC, Oxbow Advisors LLC, Kempner Capital Management Inc., Riverbridge Partners LLC and Sit Investment Associates Inc.. View Insider Buying and Selling for Roche Holding.
How do I buy Roche Holding stock?
Shares of Roche Holding can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Roche Holding stock cost?
One share of Roche Holding stock can currently be purchased for approximately $34.22.
Earnings History for Roche Holding (NASDAQ:RHHBY)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Roche Holding (NASDAQ:RHHBY)
Current Year EPS Consensus Estimate: $1.91 EPS
Next Year EPS Consensus Estimate: $2.03 EPS
Dividend History for Roche Holding (NASDAQ:RHHBY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Roche Holding (NASDAQ:RHHBY)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Roche Holding (NASDAQ:RHHBY)
Latest Headlines for Roche Holding (NASDAQ:RHHBY)
Roche Holding (RHHBY) Chart for Thursday, May, 25, 2017